Over the past decade, the use of multiple medications (clinically known as polypharmacy) has skyrocketed among older adults.

The result has been increased rates of adverse drug events. These events run the gamut from dizziness and falls to delirium, heart attack, stroke and even death.

Medication overload is especially prevalent in senior living settings, because residents tend to be older and frailer, with multiple chronic conditions.

Governments, organizations and individual facilities all have taken actions to reduce harm from adverse drug events in assisted living communities and nursing homes. Institutions and policymakers, however, still could do more to ensure that residents are not burdened by over-medication.

Here are a few recommendations for reducing medication overload, from the recently released report, “Eliminating Medication Overload: A National Action Plan”:

Recognize potential medication harms. The first step toward reducing medication overload is recognizing the harm that medications can cause for elderly and frail individuals. Administrators and clinicians all should be aware that certain medications — such as antipsychotics, blood thinners, anti-seizure meds and diuretics — are especially dangerous.

Implement regular prescription checkups. Prescription checkups are visits where the patient (and family member or caregiver) review all their medications with their primary care provider and identify unnecessary or potentially harmful meds that can be safely deprescribed (discontinued or reduced in dose).

Raise awareness of medication overload among residents and family. Residents and family members / caregivers may not be aware of the potential harms of taking multiple medications for very old and frail individuals. Even those who have concerns about the number of medications they or their loved one is taking may not feel comfortable bringing up the subject with their care team. Family members and caregivers often are the first to recognize drug side effects, so they should be empowered to start conversations with the care team about medications.


Drug treatment added to osteoporosis guidelines

The drug romosozumab (Evenity, Amgen) has been added to the Endocrine Society’s official guidelines for management of severe osteoporosis in women, the organization reported. Patients with heart conditions are not good candidates for the therapy, however.

“Romosozumab offers promising results for postmenopausal women with severe osteoporosis or who have a history of fractures,” wrote Dolores Shoback, M.D., from the San Francisco Veterans Affairs Medical Center, and colleagues. “It does, however, come with a risk of heart disease, so clinicians need to be careful when selecting patients for this therapy.”

Continue hypertension drugs despite COVID-19: ESC

The European Society of Cardiology is recommending that physicians urge their patients to continue high blood pressure medications, even though a study suggested that those medications could increase the risk of COVID-19.

Connected Living app adds coronavirus information

Thirteen-year-old Quincy, MA-based technology solution company Connected Living is updating its free public app to provide real-time updates about coronavirus disease 2019 (COVID-19) to senior living staff members, residents and families. Connected Living’s app, available on iOS and Android platforms, functions as a communication hub for senior living residents and their families, allowing them to share information on a private social feed, along with their location and activities, as well as access a concierge.

Drug information available on Alexa-enabled devices

Amazon’s Alexa and other so-called virtual assistants increasingly are used by senior living residents either on their own or as technology integrated into other systems used at their communities. Now, through a partnership with First Databank, residents and others will be able to access drug information through Alexa queries.